Management of Established Rheumatoid Arthritis

Title:

Management of Established Rheumatoid Arthritis

Topic: Rheumatology
Relevant Terms: Rheumatoid Arthritis
Primary Audience: Primary care providers
Launch Date: 02-Jun-11
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Early Diagnosis RA in Primary Care

Learning Objectives

Upon completion of the activity, participants should be able to:

  1. Integrate best practices for comanagement of rheumatoid arthritis (RA) patients with rheumatologists and other clinical specialists into patient care
  2. Appropriately manage infections in RA patients taking disease-modifying antirheumatic drug (DMARD) therapy
  3. Assess and aggressively reduce cardiovascular disease (CVD) risk in RA patients
  4. Improve communications between all members of the health care team caring for patients with RA
  5. Develop practice protocols for the treatment of patients with established RA

    Faculty

    Vivian P. Bykerk, MD—Activity Leader
    Instructor
    Harvard Medical School
    Division of Rheumatology, Allergy and Immunology
    Brigham and Women's Hospital
    Boston, Massachusetts
    Assistant Professor of Medicine
    University of Toronto
    Toronto, Canada
    Steering Committee
    David S. Kountz, MD, MBA, FACP—Activity Leader
    Senior Vice President, Medical and Academic Affairs
    Jersey Shore University Medical Center
    Associate Professor of Medicine
    Robert Wood Johnson Medical School
    New Brunswick, New Jersey
    Michael E. Weinblatt, MD—Planning Committee Co-Chair
    John R. and Eileen K. Riedman Professor of Medicine
    Harvard Medical School
    Co-Director, Clinical Rheumatology
    Division of Rheumatology, Immunology and Allergy
    Brigham and Women's Hospital
    Boston, Massachusetts
    Lauren G. Collins, MD—Planning Committee Co-Chair
    Assistant Professor of Medicine
    Department of Family and Community Medicine
    Jefferson Medical College of Thomas Jefferson University
    Philadelphia, Pennsylvania
    Clifton O. Bingham III, MD
    Associate Professor of Medicine
    Divisions of Rheumatology and Allergy and Clinical Rheumatology
    Director, Johns Hopkins Arthritis Center
    Director, Rheumatology Clinics
    Johns Hopkins University
    Baltimore, Maryland
    Joyce P. Carlone, MN, RN, FNP-BC, CCRC
    Nurse Practitioner, Division of Rheumatology
    Emory University
    Atlanta, Georgia
    Mary Suzanne Cleveland, JD (Patient/Patient Educator)
    Senior Analyst
    Kansas Health Institute
    Topeka, Kansas
    Karen H. Costenbader, MD, MPH
    Associate Physician
    Division of Rheumatology, Immunology and Allergy
    Brigham and Women's Hospital
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts
    Paul P. Doghramji, MD, FAAFP
    Medical Director for Health Services at Ursinus College
    Family Physician, Collegeville Family Practice
    Collegeville, Pennsylvania
    Release date: June 2, 2011
    Expiration date: June 2, 2012
    Estimated time to complete activity: 0.5 hours

    Co-sponsored by Curatio CME Institute and Jefferson Medical College of Thomas Jefferson University.

    Support for this activity has been provided through educational grants from Abbott Laboratories, Centocor Ortho Biotech Inc., and Pfizer Inc.
     
    Activity Overview
    Rheumatoid arthritis (RA) is a complex, chronic autoimmune condition that requires a coordinated approach between the patient, primary care provider (PCP), and rheumatologist for optimal long-term management. This ClinicalUpdate discusses the continuing management in primary care of patients with diagnosed RA. Topics include the importance of monitoring for changes in disease activity and the management and monitoring of common comorbid conditions in RA patients, including cardiovascular disease, infection, malignancies, and pulmonary complications.

    Target Audience
    This activity has been designed to meet the educational needs of PCPs.

    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Jefferson Medical College of Thomas Jefferson University is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    Jefferson Medical College of Thomas Jefferson University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Method of Participation
    There are no fees for participating in this CME activity. To receive credit during the period June 2, 2011 to June 2, 2012, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the posttest and activity evaluation form, including the certificate information section.

    To obtain a certificate of participation on the RealCME site, participants must receive a score of 75% or better on the posttest. The posttest can be accessed at the end of the activity.
    Participants who successfully complete the activity can retrieve their official CME certificate using Jefferson's online access at http://jeffline.jefferson.edu/jeffcme/RAPID. Please e-mail any questions to jeffersoncme@jefferson.edu or call us at 888 JEFF CME.

    Medium
    The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

    Disclosure
    Jefferson Medical College of Thomas Jefferson University endorses the Standards of the ACCME and the Guidelines for Commercial Support. Every effort has been made to encourage faculty to disclose any commercial relationships or personal benefit with commercial companies whose products may be discussed in this educational tool. Disclosure of a relationship is not intended to suggest or condone bias in any presentations but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
     
    Relationship information appears below:
     
    The following individuals have disclosed relevant financial relationships:
    Clifton O. Bingham III, MD:
    Grant/Research Support: BMS, Genentech, Roche, UCB
    Consultant: Celgene, Centocor Ortho Biotech Inc., Flexion, Genentech, Merck, Roche, UCB
    Joyce P. Carlone, MN, RN, FNP-BC, CCRC:
    Consultant: UCB
    Product/Speakers Bureau: UCB
    Other: UCB
    David S. Kountz, MD, MBA, FACP:
    Consultant: NiCox, Novartis
    Michael E. Weinblatt, MD:
    Grant/Research Support: Abbott Laboratories
    Consultant: Abbott Laboratories, Centocor Ortho Biotech Inc., Pfizer/Wyeth

    The following individuals have disclosed no relevant financial relationships:
    Vivian P. Bykerk, MD
    Mary Suzanne Cleveland, JD
    Lauren G. Collins, MD
    Karen H. Costenbader, MD, MPH
    Paul P. Doghramji, MD, FAAFP
     
    Jefferson Medical College of Thomas Jefferson University
    Jeanne G. Cole, EdD, FACME, Director, Office of CME, has disclosed no relevant financial relationships.

    Curatio CME Institute
    Daniel Duch, PhD, Medical Director, has disclosed no relevant financial relationships.
    Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.

    Disclaimer
    The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient's medical condition.

    Unapproved Product Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Jefferson Medical College of Thomas Jefferson University, Curatio CME Institute, Abbott Laboratories, Centocor Ortho Biotech Inc., and Pfizer Inc. do not recommend the use of any agent outside the labeled indications. When a pharmaceutical agent is discussed outside of labeling, it is identified with an (*).

    The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Jefferson Medical College of Thomas Jefferson University, Curatio CME Institute, Abbott Laboratories, Centocor Ortho Biotech Inc., or Pfizer Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy Statement
    Thomas Jefferson University (Jefferson) has created this statement to demonstrate Jefferson's commitment to on-line privacy. It discloses Jefferson information-gathering and dissemination practices for this website.

    You may visit the Jefferson website without submitting any information about yourself. For each visitor to the Jefferson website, Jefferson web server automatically recognizes only the visitor's IP address. Jefferson does collect aggregate information on what pages are visited in order to assess and improve the content of the Jefferson website. Jefferson will not, however, set any "cookies" to track visitor's identification or use of the site without prior notification. The Jefferson website may log the IP addresses of visitors, but only to administer the site and diagnose problems with the Jefferson server. IP addresses are not used to identify individuals. Jefferson has appropriate security measures in place in our physical facilities to protect against the loss, misuse or alteration of information that Jefferson has collected from the Jefferson site.

    If you send us e-mail or subscribe to one of Jefferson's on-line publications, you will be asked to submit information about yourself. Jefferson will use this information to reply to your message or forward the requested material. Jefferson does not share this information with any other partners, affiliates, vendors, members of the Jefferson Health System, or other organizations.
    This site contains links to other sites. Jefferson is not responsible for their privacy practices or content. Please note that Jefferson will not respond to any question concerning a specific medical or health condition. If you submit such a request, you will receive a standard response that you should consult with your own health care professional. Of course, Jefferson will not intentionally share the content of this type of an email with any third party. Due to the nature of electronic communications, however, Jefferson cannot and does not provide any assurances that the contents of your e-mail will not become known or accessible to third parties. WE URGE YOU NOT TO PROVIDE ANY CONFIDENTIAL INFORMATION ABOUT YOU OR YOUR HEALTH TO US VIA ELECTRONIC COMMUNICATION. If you do so, it is at your own risk.

    If Jefferson information practices change at some time in the future, Jefferson will post the policy changes to the Jefferson website to notify you of these changes.